BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Radiance Medical Systems, Inc. (RADX) Announces Regulatory Clearance of PressureWire(R) Certus for Physiological Parameter Measurements Inside the Heart


9/24/2008 10:41:22 AM

WILMINGTON, Massachusetts, September 23 /PRNewswire/ -- Radi Medical Systems Inc. today announced at the VIVA conference in Las Vegas, NV, that it has received regulatory clearance for its PressureWire(R) Certus to measure physiological parameters inside the heart.

PressureWire(R) has previously only been cleared for use in the coronary and peripheral blood vessels. With the new regulatory clearance, PressureWire(R) can be used to assess pressure measurements across heart valves and into various chambers of the heart.

"The availability of PressureWire(R) for use in extra-coronary applications is an important advance," said Ted Feldman, M.D., FSCAI, Professor of Medicine and Director, Cardiac Catheterization Laboratory, Evanston Hospital, Cardiology Division, Evanston, IL. "My own use of PressureWire(R) for assessing transvalvular gradients has made a real difference for patient management."

In addition to this new application, PressureWire(R) Certus is used in the assessment of Fractional Flow Reserve (FFR). FFR expresses the maximum achievable blood flow in a coronary artery with abnormal stenosis as a fraction of maximum blood flow in the absence of a stenosis.

"Radi continues to make strides to ensure that PressureWire(R) can be used in additional clinical areas as requested by our customers," commented Jason Rudy, Director of Marketing of Radi Medical Systems, Inc. "With this additional regulatory clearance, Radi is the only company able to provide a product that can be used in coronary, peripheral and heart pressure measurements via a 0.014" guidewire."

About Radi Medical Systems AB

Radi Medical Systems AB (Radi) develops, manufactures and sells medical devices designed to improve patient care. The company's pioneering work in the field of interventional cardiology has resulted in market-leading intravascular sensors and hemostasis management and radiology devices. Radi works closely with medical practitioners to develop solutions that address clinical needs, as well as provide clinical education support. Founded in 1988, Radi employs more than 350 people globally and has representation in more than 40 countries. The company is based in Uppsala, Sweden, and maintains a U.S. headquarters in Wilmington, MA.

For more information, visit http://www.radi.se.

CONTACT: Media Contacts: Jason Rudy, Radi Medical Systems Inc.
+1-877-337-7234 x828, jason.rudy@radi.se; Ian Stone, Russo Partners LLC,
+1-619-814-3510, ian.stone@russopartnersllc.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES